$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

[해외논문] Efficacy of methylsulfonylmethane (MSM) in osteoarthritis pain of the knee: a pilot clinical trial 원문보기

Osteoarthritis and cartilage, v.14 no.3, 2006년, pp.286 - 294  

Kim, L.S. (Southwest College Research Institute, Southwest College of Naturopathic Medicine & Health Sciences, Tempe, AZ, USA) ,  Axelrod, L.J. (Division of Clinical Sciences, Southwest College of Naturopathic Medicine & Health Sciences, Tempe, AZ, USA) ,  Howard, P. (Arthritis Health Center, USA) ,  Buratovich, N. (Department of Physical Medicine, Southwest College of Naturopathic Medicine & Health Sciences, Tempe, AZ, USA) ,  Waters, R.F. (Department of Research, Southwest College of Naturopathic Medicine & Health Sciences, Tempe, AZ, USA)

Abstract AI-Helper 아이콘AI-Helper

SummaryObjectiveOsteoarthritis (OA) is the most common form of arthritis and the second most common cause of long-term disability among middle-aged and older adults in the United States. Methylsulfonylmethane (MSM) is a popular dietary supplement used as a single agent and in combination with other ...

Keyword

참고문헌 (58)

  1. Arthritis Rheum Lawrence 41 778 1998 10.1002/1529-0131(199805)41:5<778::AID-ART4>3.0.CO;2-V Estimates of the prevalence of arthritis and selected musculoskeletal disorders in the United States 

  2. Qual Life Res Ethgen 13 321 2004 10.1023/B:QURE.0000018492.40262.d1 Social support and health-related quality of life in hip and knee osteoarthritis 

  3. JAMA Geba 287 64 2002 10.1001/jama.287.1.64 Efficacy of rofecoxib, celecoxib, and acetaminophen in osteoarthritis of the knee: a randomized trial 

  4. Rheumatology (Oxford) Gottesdiener 41 1052 2002 10.1093/rheumatology/41.9.1052 Results of a randomized, dose-ranging trial of etoricoxib in patients with osteoarthritis 

  5. Rheumatology (Oxford) Dieppe 38 73 1999 10.1093/rheumatology/38.1.73 Knee replacement surgery for osteoarthritis: effectiveness, practice variations, indications and possible determinants of utilization 

  6. Ann Intern Med Felson 133 726 2000 10.7326/0003-4819-133-9-200011070-00015 Osteoarthritis: new insights. Part 2: treatment approaches 

  7. JAMA McAlindon 283 1469 2000 10.1001/jama.283.11.1469 Glucosamine and chondroitin for treatment of osteoarthritis: a systematic quality assessment and meta-analysis 

  8. Arch Intern Med Pavelka 162 2113 2002 10.1001/archinte.162.18.2113 Glucosamine sulfate use and delay of progression of knee osteoarthritis: a 3-year, randomized, placebo-controlled, double-blind study 

  9. Lancet Reginster 357 251 2001 10.1016/S0140-6736(00)03610-2 Long-term effects of glucosamine sulphate on osteoarthritis progression: a randomised, placebo-controlled clinical trial 

  10. New Business Journal. Top Specialty Supplement Sales Chart 11. San Diego: Penton Media Inc 2004. 

  11. J Pharmacol Exp Ther Hucker 155 309 1967 Studies on the absorption, excretion and metabolism of dimethylsulfoxide (DMSO) in man 

  12. NMR Biomed Engelke 18 331 2005 10.1002/nbm.966 Dimethyl sulfone in human cerebrospinal fluid and blood plasma confirmed by one-dimensional (1)H and two-dimensional (1)H-(13)C NMR 

  13. Anticancer Res Ebisuzaki 23 453 2003 Aspirin and methylsulfonylmethane (MSM): a search for common mechanisms, with implications for cancer prevention 

  14. Ann N Y Acad Sci Alam 411 318 1983 10.1111/j.1749-6632.1983.tb47314.x Dimethyl sulfoxide inhibition of prostacyclin production in cultured aortic endothelial cells 

  15. J Lab Clin Med Beilke 110 91 1987 Effects of dimethyl sulfoxide on the oxidative function of human neutrophils 

  16. J Leukoc Biol Morton 40 322 1986 Lupus nephritis and deaths are diminished in B/W mice drinking 3% water solutions of dimethyl sulfoxide (DMSO) or dimethyl sulfone (DMSO2) 

  17. Jpn Pharmacol Ther Hasegawa 32 421 2004 Suppressive effect of methylsulfonylmethane (MSM) on type II collagen-induced arthritis in DBA/1J mice 

  18. Clin Drug Invest Usha 24 353 2004 10.2165/00044011-200424060-00005 Randomised, double-blind, parallel, placebo-controlled study of oral glucosamine, methylsulfonylmethane and their combination in osteoarthritis 

  19. Food Chem Toxicol Horvath 40 1459 2002 10.1016/S0278-6915(02)00086-8 Toxicity of methylsulfonylmethane in rats 

  20. Horstman 1999 The Arthritis Foundation's Guide to Alternative Therapies 

  21. Jacob 2003 MSM-The Definitive Guide 

  22. Patol Fiziol Eksp Ter Murav'ev Iu 37 1991 Effect of dimethyl sulfoxide and dimethyl sulfone on a destructive process in the joints of mice with spontaneous arthritis 

  23. J Rheumatol Bellamy 26 2654 1999 Perceptual variation in categorizing individuals according to American College of Rheumatology classification criteria for hand, knee, and hip osteoarthritis (OA): observations based on an Australian Twin Registry study of OA 

  24. Arthritis Rheum Altman 29 1039 1986 10.1002/art.1780290816 Development of criteria for the classification and reporting of osteoarthritis. Classification of osteoarthritis of the knee. Diagnostic and Therapeutic Criteria Committee of the American Rheumatism Association 

  25. Arthritis Rheum Hochberg 35 498 1992 10.1002/art.1780350502 The American College of Rheumatology 1991 revised criteria for the classification of global functional status in rheumatoid arthritis 

  26. J Rheumatol Suppl Menkes 27 13 1991 Radiographic criteria for classification of osteoarthritis 

  27. J Rheumatol Bellamy 15 1833 1988 Validation study of WOMAC: a health status instrument for measuring clinically important patient relevant outcomes to antirheumatic drug therapy in patients with osteoarthritis of the hip or knee 

  28. Arthritis Care Res Davies 12 172 1999 10.1002/1529-0131(199906)12:3<172::AID-ART4>3.0.CO;2-Y Comparison of the responsiveness and relative effect size of the western Ontario and McMaster Universities Osteoarthritis Index and the short-form Medical Outcomes Study Survey in a randomized, clinical trial of osteoarthritis patients 

  29. Psychosom Med Hauser 66 954 2004 10.1097/01.psy.0000145824.82125.a8 Biopsychosocial predictors of health-related quality of life in patients with chronic hepatitis C 

  30. Med Care Katz 30 917 1992 10.1097/00005650-199210000-00004 Comparative measurement sensitivity of short and longer health status instruments 

  31. Rheumatology (Oxford) Karlsson 41 1240 2002 10.1093/rheumatology/41.11.1240 Comparison of two hyaluronan drugs and placebo in patients with knee osteoarthritis. A controlled, randomized, double-blind, parallel-design multicentre study 

  32. BMJ Wald 325 1202 2002 10.1136/bmj.325.7374.1202 Homocysteine and cardiovascular disease: evidence on causality from a meta-analysis 

  33. Annu Rev Nutr Selhub 19 217 1999 10.1146/annurev.nutr.19.1.217 Homocysteine metabolism 

  34. Ital J Neurol Sci Pace 18 73 1997 10.1007/BF01999566 Paclitaxel neurotoxicity: clinical and neurophysiological study of 23 patients 

  35. Epilepsy Res Aldenkamp 20 229 1995 10.1016/0920-1211(94)00082-8 The Neurotoxicity Scale: the validity of a patient-based scale, assessing neurotoxicity 

  36. Epilepsy Res Aldenkamp 27 165 1997 10.1016/S0920-1211(97)01036-X The Neurotoxicity Scale-II. Results of a patient-based scale assessing neurotoxicity in patients with epilepsy 

  37. Altman 1999 Practical Statistics for Medical Research 

  38. Osteoarthritis Cartilage Altman 4 217 1996 10.1016/S1063-4584(05)80101-3 Design and conduct of clinical trials in patients with osteoarthritis: recommendations from a task force of the Osteoarthritis Research Society. Results from a workshop 

  39. J Rheumatol Bellamy 20 999 1993 A multicenter study of tenoxicam and diclofenac in patients with osteoarthritis of the knee 

  40. J Rheumatol Ehrich 26 2438 1999 Effect of specific COX-2 inhibition in osteoarthritis of the knee: a 6 week double blind, placebo controlled pilot study of rofecoxib. Rofecoxib Osteoarthritis Pilot Study Group 

  41. Int J Anti Aging Med Lawrence 1 50 1998 Methylsulfonylmethane (MSM): a double-blind study of its use in degenerative arthritis 

  42. J Altern Complement Med Barrager 8 167 2002 10.1089/107555302317371451 A multicentered, open-label trial on the safety and efficacy of methylsulfonylmethane in the treatment of seasonal allergic rhinitis 

  43. N Engl J Med Danesh 350 1387 2004 10.1056/NEJMoa032804 C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease 

  44. Circulation Pearson 107 499 2003 10.1161/01.CIR.0000052939.59093.45 Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association 

  45. Br Med J Bottiger 2 85 1967 10.1136/bmj.2.5544.85 Normal erythrocyte sedimentation rate and age 

  46. Lipids Dhanakoti 22 643 1987 10.1007/BF02533942 Response of urinary malondialdehyde to factors that stimulate lipid peroxidation in vivo 

  47. J Biol Chem Niedernhofer 278 31426 2003 10.1074/jbc.M212549200 Malondialdehyde, a product of lipid peroxidation, is mutagenic in human cells 

  48. Am J Clin Nutr McKinley 73 759 2001 10.1093/ajcn/73.4.759 Low-dose vitamin B-6 effectively lowers fasting plasma homocysteine in healthy elderly persons who are folate and riboflavin replete 

  49. Clin Orthop Cheras 57 1997 Hypercoagulability and hypofibrinolysis in primary osteoarthritis 

  50. J Rheumatol Sturmer 25 1827 1998 Serum cholesterol and osteoarthritis. The baseline examination of the Ulm Osteoarthritis Study 

  51. J Clin Hypertens (Greenwich) Dinavahi 6 494 2004 10.1111/j.1524-6175.2004.03643.x Relationship of homocysteine with cardiovascular disease and blood pressure 

  52. Stroke Sacco 35 2263 2004 10.1161/01.STR.0000142374.33919.92 Homocysteine and the risk of ischemic stroke in a triethnic cohort: the Northern Manhattan Study 

  53. Arthritis Res Ther Yudoh 7 R380 2005 10.1186/ar1499 Potential involvement of oxidative stress in cartilage senescence and development of osteoarthritis: oxidative stress induces chondrocyte telomere instability and downregulation of chondrocyte function 

  54. Best Pract Res Clin Rheumatol Ghosh 15 693 2001 10.1053/berh.2001.0188 Vascular mechanisms in osteoarthritis 

  55. JAMA Esposito 292 1440 2004 10.1001/jama.292.12.1440 Effect of a Mediterranean-style diet on endothelial dysfunction and markers of vascular inflammation in the metabolic syndrome: a randomized trial 

  56. Arch Intern Med Day 160 1781 2000 10.1001/archinte.160.12.1781 A randomized trial of the efficacy and tolerability of the COX-2 inhibitor rofecoxib vs ibuprofen in patients with osteoarthritis. Rofecoxib/Ibuprofen Comparator Study Group 

  57. Arch Intern Med Watson 160 2998 2000 10.1001/archinte.160.19.2998 Gastrointestinal tolerability of the selective cyclooxygenase-2 (COX-2) inhibitor rofecoxib compared with nonselective COX-1 and COX-2 inhibitors in osteoarthritis 

  58. J Fam Pract Buescher 53 501 2004 Clinical inquiries. Does acetaminophen and NSAID combined relieve osteoarthritis pain better than either alone? 

관련 콘텐츠

오픈액세스(OA) 유형

BRONZE

출판사/학술단체 등이 한시적으로 특별한 프로모션 또는 일정기간 경과 후 접근을 허용하여, 출판사/학술단체 등의 사이트에서 이용 가능한 논문

이 논문과 함께 이용한 콘텐츠

저작권 관리 안내
섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로